Benzodiazepine discontinuation, end of intervention · adults who withdraw from chronic benzodiazepine use
It is very uncertain whether paroxetine changes benzodiazepine discontinuation, end of intervention compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Treatment responseCGI‐I · people with anxiety and comorbid alcohol use disorders
It is very uncertain whether paroxetine changes treatment responseCGI‐I compared with placebo (very low certainty).
1 finding from 1 review
Symptom severity reductionLSAS · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with anxiety and comorbid alcohol use disorders
It is very uncertain whether paroxetine changes treatment acceptability compared with placebo (very low certainty).
1 finding from 1 review
Frequency of use % of heavy drinking days at the end of treatment · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Percent of days abstinent · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Drinks per drinking day · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Depression symptom reduction · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Repetition of SH at post‐intervention · self‐harm in adults
Newer generation antidepressants (NGAs) showed no clear difference in repetition of SH by post‐intervention (NGA class) ‐ Paroxetine vs.… compared with placebo (low certainty).
1 finding from 1 review
OR 0.55 [0.24, 1.29]
Studies not reported
Low
Intervention not reported
citalopram:paroxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
paroxetine:sertraline · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
paroxetine:venlafaxine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
vilazodone:paroxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
vortioxetine:paroxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
paroxetine:placebo · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
paroxetine:desvenlafaxine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate